IL-6 and CRP Levels in Breast Cancer Patients
Author Information
Author(s): Ravishankaran Praveen, Karunanithi R
Primary Institution: Coimbatore Medical College Hospital
Hypothesis
The study aims to determine the preoperative serum levels of IL-6 and CRP in breast carcinoma and correlate them with disease staging and prognosis.
Conclusion
Serum levels of IL-6 correlate well with tumor invasion, lymph node metastasis, distant metastasis, and TNM staging in breast cancer.
Supporting Evidence
- IL-6 levels were significantly correlated with tumor size and lymph node metastasis.
- Higher IL-6 levels were associated with distant metastasis.
- CRP levels did not significantly correlate with overall survival.
Takeaway
This study found that higher levels of a substance called IL-6 in the blood can mean more serious breast cancer, while another substance, CRP, isn't as helpful for understanding the cancer's severity.
Methodology
59 female patients with breast cancer were evaluated for serum IL-6 and CRP levels using ELISA and immunoturbidimetry, respectively.
Limitations
A larger sample size and longer follow-up are needed for more definitive conclusions.
Participant Demographics
The study included 59 women with a median age of 59.11 years (range, 36-85 years).
Statistical Information
P-Value
P < 0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website